Farrell PM - Search Results

1

Outcomes of infants born during the first 9 years of CF newborn screening in the United States: A retrospective Cystic Fibrosis Foundation Patient Registry cohort study.

Martiniano SL, Elbert AA, Farrell PM, Ren CL, Sontag MK, Wu R, McColley SA. Martiniano SL, et al. Among authors: farrell pm. Pediatr Pulmonol. 2021 Dec;56(12):3758-3767. doi: 10.1002/ppul.25658. Epub 2021 Sep 13. Pediatr Pulmonol. 2021. PMID: 34469079

2

Newborn screening for cystic fibrosis. The Cystic Fibrosis Neonatal Screening Study Group.

Farrell PM, Mischler EH. Farrell PM, et al. Adv Pediatr. 1992;39:35-70. Adv Pediatr. 1992. PMID: 1442316 Review.

3

Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing.

Tluczek A, Mischler EH, Farrell PM, Fost N, Peterson NM, Carey P, Bruns WT, McCarthy C. Tluczek A, et al. Among authors: farrell pm. J Dev Behav Pediatr. 1992 Jun;13(3):181-6. J Dev Behav Pediatr. 1992. PMID: 1613113

4

Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee.

Ramsey BW, Farrell PM, Pencharz P. Ramsey BW, et al. Among authors: farrell pm. Am J Clin Nutr. 1992 Jan;55(1):108-16. doi: 10.1093/ajcn/55.1.108. Am J Clin Nutr. 1992. PMID: 1728810 Review.

5

Current issues in neonatal screening for cystic fibrosis and implications of the CF gene discovery.

Farrell PM, Mischler EH, Fost NC, Wilfond BS, Tluczek A, Gregg RG, Bruns WT, Hassemer DJ, Laessig RH. Farrell PM, et al. Pediatr Pulmonol Suppl. 1991;7:11-8. doi: 10.1002/ppul.1950110704. Pediatr Pulmonol Suppl. 1991. PMID: 1782123 Review.

6

Psychological impact of false-positive results when screening for cystic fibrosis.

Tluczek A, Mischler EH, Bowers B, Peterson NM, Morris ME, Farrell PM, Bruns WT, Colby H, McCarthy C, Fost N, et al. Tluczek A, et al. Among authors: farrell pm. Pediatr Pulmonol Suppl. 1991;7:29-37. doi: 10.1002/ppul.1950110707. Pediatr Pulmonol Suppl. 1991. PMID: 1782126 No abstract available.

7

Nutritional assessment of infants with cystic fibrosis diagnosed through screening.

Mischler EH, Marcus MS, Sondel SA, Laxova A, Carey P, Langhough R, Farrell PM. Mischler EH, et al. Among authors: farrell pm. Pediatr Pulmonol Suppl. 1991;7:56-63. doi: 10.1002/ppul.1950110712. Pediatr Pulmonol Suppl. 1991. PMID: 1782132 Clinical Trial.

8

Laboratory quality control issues related to screening newborns for cystic fibrosis using immunoreactive trypsin.

Hassemer DJ, Laessig RH, Hoffman GL, Farrell PM. Hassemer DJ, et al. Among authors: farrell pm. Pediatr Pulmonol Suppl. 1991;7:76-83. doi: 10.1002/ppul.1950110716. Pediatr Pulmonol Suppl. 1991. PMID: 1782137 Clinical Trial.

9

Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention.

Marcus MS, Sondel SA, Farrell PM, Laxova A, Carey PM, Langhough R, Mischler EH. Marcus MS, et al. Among authors: farrell pm. Am J Clin Nutr. 1991 Sep;54(3):578-85. doi: 10.1093/ajcn/54.3.578. Am J Clin Nutr. 1991. PMID: 1877513

10

Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels.

Rock MJ, Mischler EH, Farrell PM, Wei LJ, Bruns WT, Hassemer DJ, Laessig RH. Rock MJ, et al. Among authors: farrell pm. Pediatrics. 1990 Jun;85(6):1001-7. Pediatrics. 1990. PMID: 2187173 Clinical Trial.

11

Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test.

Rock MJ, Mischler EH, Farrell PM, Bruns WT, Hassemer DJ, Laessig RH. Rock MJ, et al. Among authors: farrell pm. Pediatr Pulmonol. 1989;6(1):42-8. doi: 10.1002/ppul.1950060111. Pediatr Pulmonol. 1989. PMID: 2704582

12

Rapid methylprednisolone clearance in a patient with cystic fibrosis.

Green CG, Kraus CK, Lemanske RF, Farrell PM, Jusko WJ. Green CG, et al. Among authors: farrell pm. Drug Intell Clin Pharm. 1988 Nov;22(11):876-8. doi: 10.1177/106002808802201107. Drug Intell Clin Pharm. 1988. PMID: 3234253

13

Predigested formula for infants with cystic fibrosis.

Farrell PM, Mischler EH, Sondel SA, Palta M. Farrell PM, et al. J Am Diet Assoc. 1987 Oct;87(10):1353-6. J Am Diet Assoc. 1987. PMID: 3309012 Clinical Trial.

14

Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols.

Gregg RG, Wilfond BS, Farrell PM, Laxova A, Hassemer D, Mischler EH. Gregg RG, et al. Among authors: farrell pm. Am J Hum Genet. 1993 Mar;52(3):616-26. Am J Hum Genet. 1993. PMID: 7680526 Free PMC article.

15

Newborn screening for cystic fibrosis in Wisconsin: first application of population-based molecular genetics testing.

Farrell PM, Aronson RA, Hoffman G, Laessig RH. Farrell PM, et al. Wis Med J. 1994 Aug;93(8):415-21. Wis Med J. 1994. PMID: 7975706

16

Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis. Implications for neonatal screening.

Wilfond BS, Farrell PM, Laxova A, Mischler E. Wilfond BS, et al. Among authors: farrell pm. Clin Pediatr (Phila). 1994 Jan;33(1):2-7. doi: 10.1177/000992289403300101. Clin Pediatr (Phila). 1994. PMID: 8156723

17

Wisconsin cystic fibrosis chest radiograph scoring system.

Weatherly MR, Palmer CG, Peters ME, Green CG, Fryback D, Langhough R, Farrell PM. Weatherly MR, et al. Among authors: farrell pm. Pediatrics. 1993 Feb;91(2):488-95. Pediatrics. 1993. PMID: 8424032

18

Effect of linoleic acid intake on growth of infants with cystic fibrosis.

van Egmond AW, Kosorok MR, Koscik R, Laxova A, Farrell PM. van Egmond AW, et al. Among authors: farrell pm. Am J Clin Nutr. 1996 May;63(5):746-52. doi: 10.1093/ajcn/63.5.746. Am J Clin Nutr. 1996. PMID: 8615359 Clinical Trial.

19

Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.

Farrell PM, Koscik RE. Farrell PM, et al. Pediatrics. 1996 Apr;97(4):524-8. Pediatrics. 1996. PMID: 8632940

20

The incidence of cystic fibrosis.

Kosorok MR, Wei WH, Farrell PM. Kosorok MR, et al. Among authors: farrell pm. Stat Med. 1996 Mar 15;15(5):449-62. doi: 10.1002/(SICI)1097-0258(19960315)15:5<449::AID-SIM173>3.0.CO;2-X. Stat Med. 1996. PMID: 8668871

21

Newborn screening: principles and practice.

Allen DB, Farrell PM. Allen DB, et al. Among authors: farrell pm. Adv Pediatr. 1996;43:231-70. Adv Pediatr. 1996. PMID: 8794179 Review. No abstract available.

22

Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis.

Farrell PM, Shen G, Splaingard M, Colby CE, Laxova A, Kosorok MR, Rock MJ, Mischler EH. Farrell PM, et al. Pediatrics. 1997 Nov;100(5):E2. doi: 10.1542/peds.100.5.e2. Pediatrics. 1997. PMID: 9346996 Clinical Trial.

23

Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns WT, Splaingard M, Mischler EH. Farrell PM, et al. N Engl J Med. 1997 Oct 2;337(14):963-9. doi: 10.1056/NEJM199710023371403. N Engl J Med. 1997. PMID: 9395429 Free article. Clinical Trial.

24

Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition.

Lai HC, Kosorok MR, Sondel SA, Chen ST, FitzSimmons SC, Green CG, Shen G, Walker S, Farrell PM. Lai HC, et al. Among authors: farrell pm. J Pediatr. 1998 Mar;132(3 Pt 1):478-85. doi: 10.1016/s0022-3476(98)70024-1. J Pediatr. 1998. PMID: 9544905

25

Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling.

Mischler EH, Wilfond BS, Fost N, Laxova A, Reiser C, Sauer CM, Makholm LM, Shen G, Feenan L, McCarthy C, Farrell PM. Mischler EH, et al. Among authors: farrell pm. Pediatrics. 1998 Jul;102(1 Pt 1):44-52. doi: 10.1542/peds.102.1.44. Pediatrics. 1998. PMID: 9651412 Clinical Trial.

26

Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis.

Kosorok MR, Jalaluddin M, Farrell PM, Shen G, Colby CE, Laxova A, Rock MJ, Splaingard M. Kosorok MR, et al. Among authors: farrell pm. Pediatr Pulmonol. 1998 Aug;26(2):81-8. doi: 10.1002/(sici)1099-0496(199808)26:2<81::aid-ppul2>3.0.co;2-k. Pediatr Pulmonol. 1998. PMID: 9727757

27

Comparison of growth status of patients with cystic fibrosis between the United States and Canada.

Lai HC, Corey M, FitzSimmons S, Kosorok MR, Farrell PM. Lai HC, et al. Among authors: farrell pm. Am J Clin Nutr. 1999 Mar;69(3):531-8. doi: 10.1093/ajcn/69.3.531. Am J Clin Nutr. 1999. PMID: 10075341

28

Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening.

Lai HC, Kosorok MR, Laxova A, Davis LA, FitzSimmon SC, Farrell PM. Lai HC, et al. Among authors: farrell pm. Pediatrics. 2000 Jan;105(1 Pt 1):53-61. doi: 10.1542/peds.105.1.53. Pediatrics. 2000. PMID: 10617704

29

Wisconsin cystic fibrosis chest radiograph scoring system: validation and standardization for application to longitudinal studies.

Koscik RE, Kosorok MR, Farrell PM, Collins J, Peters ME, Laxova A, Green CG, Zeng L, Rusakow LS, Hardie RC, Campbell PW, Gurney JW. Koscik RE, et al. Among authors: farrell pm. Pediatr Pulmonol. 2000 Jun;29(6):457-67. doi: 10.1002/(sici)1099-0496(200006)29:6<457::aid-ppul8>3.0.co;2-9. Pediatr Pulmonol. 2000. PMID: 10821728

30

Improving the health of patients with cystic fibrosis through newborn screening. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

Farrell PM. Farrell PM. Adv Pediatr. 2000;47:79-115. Adv Pediatr. 2000. PMID: 10959441 No abstract available.

31

Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.

Ciske DJ, Haavisto A, Laxova A, Rock LZ, Farrell PM. Ciske DJ, et al. Among authors: farrell pm. Pediatrics. 2001 Apr;107(4):699-705. doi: 10.1542/peds.107.4.699. Pediatrics. 2001. PMID: 11335747

32

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.

Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM. Kosorok MR, et al. Among authors: farrell pm. Pediatr Pulmonol. 2001 Oct;32(4):277-87. doi: 10.1002/ppul.2009.abs. Pediatr Pulmonol. 2001. PMID: 11568988

33

A debate on why my state (province) should or should not conduct newborn screening for cystic fibrosis (14th Annual North American Cystic Fibrosis Conference).

Wagener JS, Farrell PM, Corey M. Wagener JS, et al. Among authors: farrell pm. Pediatr Pulmonol. 2001 Nov;32(5):385-96. doi: 10.1002/ppul.1148. Pediatr Pulmonol. 2001. PMID: 11596164 No abstract available.

34

Delayed diagnosis of US females with cystic fibrosis.

Lai HC, Kosorok MR, Laxova A, Makholm LM, Farrell PM. Lai HC, et al. Among authors: farrell pm. Am J Epidemiol. 2002 Jul 15;156(2):165-73. doi: 10.1093/aje/kwf014. Am J Epidemiol. 2002. PMID: 12117708

35

Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.

Lee DS, Rosenberg MA, Peterson A, Makholm L, Hoffman G, Laessig RH, Farrell PM. Lee DS, et al. Among authors: farrell pm. J Pediatr. 2003 Jun;142(6):617-23. doi: 10.1067/mpd.2003.209. J Pediatr. 2003. PMID: 12838188

36

Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis.

Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, Makholm LM, Rock MJ, Splaingard ML. Farrell PM, et al. Pediatr Pulmonol. 2003 Sep;36(3):230-40. doi: 10.1002/ppul.10336. Pediatr Pulmonol. 2003. PMID: 12910585

37

Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis.

Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, Rock MJ, Splaingard ML. Farrell PM, et al. Am J Respir Crit Care Med. 2003 Nov 1;168(9):1100-8. doi: 10.1164/rccm.200303-434OC. Epub 2003 Aug 13. Am J Respir Crit Care Med. 2003. PMID: 12917228 Clinical Trial.

38

Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition.

Koscik RL, Farrell PM, Kosorok MR, Zaremba KM, Laxova A, Lai HC, Douglas JA, Rock MJ, Splaingard ML. Koscik RL, et al. Among authors: farrell pm. Pediatrics. 2004 Jun;113(6):1549-58. doi: 10.1542/peds.113.6.1549. Pediatrics. 2004. PMID: 15173473 Clinical Trial.

39

Longitudinal pulmonary status of cystic fibrosis children with meconium ileus.

Li Z, Lai HJ, Kosorok MR, Laxova A, Rock MJ, Splaingard ML, Farrell PM. Li Z, et al. Among authors: farrell pm. Pediatr Pulmonol. 2004 Oct;38(4):277-84. doi: 10.1002/ppul.20092. Pediatr Pulmonol. 2004. PMID: 15334503 Clinical Trial.

40

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML. Li Z, et al. Among authors: farrell pm. JAMA. 2005 Feb 2;293(5):581-8. doi: 10.1001/jama.293.5.581. JAMA. 2005. PMID: 15687313

41

Assessing the cost of cystic fibrosis diagnosis and treatment.

Rosenberg MA, Farrell PM. Rosenberg MA, et al. Among authors: farrell pm. J Pediatr. 2005 Sep;147(3 Suppl):S101-5. doi: 10.1016/j.jpeds.2005.08.018. J Pediatr. 2005. PMID: 16202771 Review.

42

Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!

Farrell PM, Lai HJ, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Hoffman G, Laessig R, Rock MJ, Splaingard ML. Farrell PM, et al. J Pediatr. 2005 Sep;147(3 Suppl):S30-6. doi: 10.1016/j.jpeds.2005.08.012. J Pediatr. 2005. PMID: 16202779 Clinical Trial.

43

The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data.

Lai HJ, Cheng Y, Farrell PM. Lai HJ, et al. Among authors: farrell pm. J Pediatr. 2005 Sep;147(3 Suppl):S57-63. doi: 10.1016/j.jpeds.2005.08.014. J Pediatr. 2005. PMID: 16202784

44

Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.

Rock MJ, Hoffman G, Laessig RH, Kopish GJ, Litsheim TJ, Farrell PM. Rock MJ, et al. Among authors: farrell pm. J Pediatr. 2005 Sep;147(3 Suppl):S73-7. doi: 10.1016/j.jpeds.2005.08.004. J Pediatr. 2005. PMID: 16202788

45

Newborn screening for cystic fibrosis: parents' preferences regarding counseling at the time of infants' sweat test.

Tluczek A, Koscik RL, Modaff P, Pfeil D, Rock MJ, Farrell PM, Lifchez C, Freeman ME, Gershan W, Zaleski C, Sullivan B. Tluczek A, et al. Among authors: farrell pm. J Genet Couns. 2006 Aug;15(4):277-91. doi: 10.1007/s10897-006-9031-x. J Genet Couns. 2006. PMID: 16865559

46

Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.

Comeau AM, Accurso FJ, White TB, Campbell PW 3rd, Hoffman G, Parad RB, Wilfond BS, Rosenfeld M, Sontag MK, Massie J, Farrell PM, O'Sullivan BP; Cystic Fibrosis Foundation. Comeau AM, et al. Among authors: farrell pm. Pediatrics. 2007 Feb;119(2):e495-518. doi: 10.1542/peds.2006-1993. Pediatrics. 2007. PMID: 17272609

47

Is newborn screening for cystic fibrosis a basic human right?

Farrell PM. Farrell PM. J Cyst Fibros. 2008 May;7(3):262-5. doi: 10.1016/j.jcf.2008.01.001. Epub 2008 Feb 11. J Cyst Fibros. 2008. PMID: 18262856 Free PMC article.

48

Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ, Campbell PW 3rd; Cystic Fibrosis Foundation. Farrell PM, et al. J Pediatr. 2008 Aug;153(2):S4-S14. doi: 10.1016/j.jpeds.2008.05.005. J Pediatr. 2008. PMID: 18639722 Free PMC article.

49

Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.

Kloosterboer M, Hoffman G, Rock M, Gershan W, Laxova A, Li Z, Farrell PM. Kloosterboer M, et al. Among authors: farrell pm. Pediatrics. 2009 Feb;123(2):e338-46. doi: 10.1542/peds.2008-1681. Pediatrics. 2009. PMID: 19171585

50

Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis.

Lai HJ, Shoff SM, Farrell PM; Wisconsin Cystic Fibrosis Neonatal Screening Group. Lai HJ, et al. Among authors: farrell pm. Pediatrics. 2009 Feb;123(2):714-22. doi: 10.1542/peds.2007-3089. Pediatrics. 2009. PMID: 19171643 Free PMC article.

51

Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis.

Farrell PM, Collins J, Broderick LS, Rock MJ, Li Z, Kosorok MR, Laxova A, Gershan WM, Brody AS. Farrell PM, et al. Radiology. 2009 Aug;252(2):534-43. doi: 10.1148/radiol.2522081882. Radiology. 2009. PMID: 19703887 Free PMC article.

52

Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond.

Cystic Fibrosis Foundation; Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, Rock MJ, Farrell PM, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation, et al. Among authors: farrell pm. J Pediatr. 2009 Dec;155(6 Suppl):S106-16. doi: 10.1016/j.jpeds.2009.09.003. J Pediatr. 2009. PMID: 19914443 Free PMC article.

53

Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Cystic Fibrosis Foundation; Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation, et al. Among authors: farrell pm. J Pediatr. 2009 Dec;155(6 Suppl):S73-93. doi: 10.1016/j.jpeds.2009.09.001. J Pediatr. 2009. PMID: 19914445 Free PMC article.

54

Pulmonary outcome differences in U.S. and French cystic fibrosis cohorts diagnosed through newborn screening.

Walsh AC, Rault G, Li Z, Scotet V, Duguépéroux I, Férec C, Roussey M, Laxova A, Farrell PM; participating CF centres of Brittany, France. Walsh AC, et al. Among authors: farrell pm. J Cyst Fibros. 2010 Jan;9(1):44-50. doi: 10.1016/j.jcf.2009.10.004. Epub 2009 Nov 18. J Cyst Fibros. 2010. PMID: 19926349 Free PMC article.

55

Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening.

Hayes D Jr, Farrell PM, Li Z, West SE. Hayes D Jr, et al. Among authors: farrell pm. Pediatr Pulmonol. 2010 Jan;45(1):55-61. doi: 10.1002/ppul.21083. Pediatr Pulmonol. 2010. PMID: 20025049 Free PMC article.

56

Opportunities for quality improvement in cystic fibrosis newborn screening.

Groose MK, Reynolds R, Li Z, Farrell PM. Groose MK, et al. Among authors: farrell pm. J Cyst Fibros. 2010 Jul;9(4):284-7. doi: 10.1016/j.jcf.2010.04.001. Epub 2010 May 14. J Cyst Fibros. 2010. PMID: 20471332 Free PMC article.

57

Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes.

Hayes D Jr, West SE, Rock MJ, Li Z, Splaingard ML, Farrell PM. Hayes D Jr, et al. Among authors: farrell pm. Pediatr Pulmonol. 2010 Jul;45(7):708-16. doi: 10.1002/ppul.21263. Pediatr Pulmonol. 2010. PMID: 20575089 Free PMC article. Clinical Trial.

58

The need for quality improvement in sweat testing infants after newborn screening for cystic fibrosis.

Legrys VA, McColley SA, Li Z, Farrell PM. Legrys VA, et al. Among authors: farrell pm. J Pediatr. 2010 Dec;157(6):1035-7. doi: 10.1016/j.jpeds.2010.07.053. Epub 2010 Sep 16. J Pediatr. 2010. PMID: 20843526 Free PMC article.

59

Relationships among health-related quality of life, pulmonary health, and newborn screening for cystic fibrosis.

Tluczek A, Becker T, Laxova A, Grieve A, Gilles CNR, Rock MJ, Gershan WM, Green CG, Farrell PM. Tluczek A, et al. Among authors: farrell pm. Chest. 2011 Jul;140(1):170-177. doi: 10.1378/chest.10-1504. Epub 2010 Nov 24. Chest. 2011. PMID: 21106659 Free PMC article.

60

Optimal DNA tier for the IRT/DNA algorithm determined by CFTR mutation results over 14 years of newborn screening.

Baker MW, Groose M, Hoffman G, Rock M, Levy H, Farrell PM. Baker MW, et al. Among authors: farrell pm. J Cyst Fibros. 2011 Jul;10(4):278-81. doi: 10.1016/j.jcf.2011.02.001. Epub 2011 Mar 8. J Cyst Fibros. 2011. PMID: 21388895 Free PMC article.

61

Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program.

Jadin SA, Wu GS, Zhang Z, Shoff SM, Tippets BM, Farrell PM, Miller T, Rock MJ, Levy H, Lai HJ. Jadin SA, et al. Among authors: farrell pm. Am J Clin Nutr. 2011 May;93(5):1038-47. doi: 10.3945/ajcn.110.004119. Epub 2011 Mar 23. Am J Clin Nutr. 2011. PMID: 21430114 Free PMC article.

62

Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis.

Sanders DB, Li Z, Brody AS, Farrell PM. Sanders DB, et al. Among authors: farrell pm. Am J Respir Crit Care Med. 2011 Oct 1;184(7):816-21. doi: 10.1164/rccm.201105-0816OC. Am J Respir Crit Care Med. 2011. PMID: 21737586 Free PMC article.

63

Factors accounting for a missed diagnosis of cystic fibrosis after newborn screening.

Rock MJ, Levy H, Zaleski C, Farrell PM. Rock MJ, et al. Among authors: farrell pm. Pediatr Pulmonol. 2011 Dec;46(12):1166-74. doi: 10.1002/ppul.21509. Epub 2011 Aug 24. Pediatr Pulmonol. 2011. PMID: 22081556 Free PMC article.

64

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies.

Sanders DB, Lai HJ, Rock MJ, Farrell PM. Sanders DB, et al. Among authors: farrell pm. J Cyst Fibros. 2012 Mar;11(2):150-3. doi: 10.1016/j.jcf.2011.10.002. Epub 2011 Nov 21. J Cyst Fibros. 2012. PMID: 22104951 Free PMC article.

65

Regional differences in the evolution of lung disease in children with cystic fibrosis.

Li Z, Sanders DB, Rock MJ, Kosorok MR, Collins J, Green CG, Brody AS, Farrell PM. Li Z, et al. Among authors: farrell pm. Pediatr Pulmonol. 2012 Jul;47(7):635-40. doi: 10.1002/ppul.21604. Epub 2011 Dec 7. Pediatr Pulmonol. 2012. PMID: 22162514 Free PMC article.

66

The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis.

Sanders DB, Li Z, Rock MJ, Brody AS, Farrell PM. Sanders DB, et al. Among authors: farrell pm. Pediatr Pulmonol. 2012 Jun;47(6):567-73. doi: 10.1002/ppul.21621. Epub 2011 Dec 13. Pediatr Pulmonol. 2012. PMID: 22170734 Free PMC article.

67

A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.

Wells J, Rosenberg M, Hoffman G, Anstead M, Farrell PM. Wells J, et al. Among authors: farrell pm. Pediatrics. 2012 Feb;129(2):e339-47. doi: 10.1542/peds.2011-0096. Epub 2012 Jan 30. Pediatrics. 2012. PMID: 22291119 Free PMC article.

68

Nutritional status is associated with health-related quality of life in children with cystic fibrosis aged 9-19 years.

Shoff SM, Tluczek A, Laxova A, Farrell PM, Lai HJ. Shoff SM, et al. Among authors: farrell pm. J Cyst Fibros. 2013 Dec;12(6):746-53. doi: 10.1016/j.jcf.2013.01.006. Epub 2013 Feb 12. J Cyst Fibros. 2013. PMID: 23410621 Free PMC article.

69

Long-term follow-up of cystic fibrosis newborn screening: psychosocial functioning of adolescents and young adults.

Tluczek A, Laxova A, Grieve A, Heun A, Brown RL, Rock MJ, Gershan WM, Farrell PM. Tluczek A, et al. Among authors: farrell pm. J Cyst Fibros. 2014 Mar;13(2):227-34. doi: 10.1016/j.jcf.2013.10.001. Epub 2013 Oct 21. J Cyst Fibros. 2014. PMID: 24157354 Free PMC article.

70

Risk factors for the progression of cystic fibrosis lung disease throughout childhood.

Sanders DB, Li Z, Laxova A, Rock MJ, Levy H, Collins J, Ferec C, Farrell PM. Sanders DB, et al. Among authors: farrell pm. Ann Am Thorac Soc. 2014 Jan;11(1):63-72. doi: 10.1513/AnnalsATS.201309-303OC. Ann Am Thorac Soc. 2014. PMID: 24261460 Free PMC article.

71

Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.

Baker MW, Atkins AE, Cordovado SK, Hendrix M, Earley MC, Farrell PM. Baker MW, et al. Among authors: farrell pm. Genet Med. 2016 Mar;18(3):231-8. doi: 10.1038/gim.2014.209. Epub 2015 Feb 12. Genet Med. 2016. PMID: 25674778 Free PMC article.

72

New challenges in the diagnosis and management of cystic fibrosis.

Levy H, Farrell PM. Levy H, et al. Among authors: farrell pm. J Pediatr. 2015 Jun;166(6):1337-41. doi: 10.1016/j.jpeds.2015.03.042. J Pediatr. 2015. PMID: 26008169 Free PMC article. No abstract available.

73

Changing incidence of cystic fibrosis in Wisconsin, USA.

Parker-McGill K, Nugent M, Bersie R, Hoffman G, Rock M, Baker M, Farrell PM, Simpson P, Levy H. Parker-McGill K, et al. Among authors: farrell pm. Pediatr Pulmonol. 2015 Nov;50(11):1065-1072. doi: 10.1002/ppul.23265. Epub 2015 Aug 10. Pediatr Pulmonol. 2015. PMID: 26258862 Free PMC article.

74

Refining the continuum of CFTR-associated disorders in the era of newborn screening.

Levy H, Nugent M, Schneck K, Stachiw-Hietpas D, Laxova A, Lakser O, Rock M, Dahmer MK, Biller J, Nasr SZ, Baker M, McColley SA, Simpson P, Farrell PM. Levy H, et al. Among authors: farrell pm. Clin Genet. 2016 May;89(5):539-49. doi: 10.1111/cge.12711. Epub 2016 Jan 20. Clin Genet. 2016. PMID: 26671754 Free PMC article.

75

Pubertal Height Growth and Adult Height in Cystic Fibrosis After Newborn Screening.

Zhang Z, Lindstrom MJ, Farrell PM, Lai HJ; Wisconsin Cystic Fibrosis Neonatal Screening Group. Zhang Z, et al. Among authors: farrell pm. Pediatrics. 2016 May;137(5):e20152907. doi: 10.1542/peds.2015-2907. Epub 2016 Apr 5. Pediatrics. 2016. PMID: 27244789 Free PMC article. Clinical Trial.

76

Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis.

Levy JF, Rosenberg MA, Farrell PM. Levy JF, et al. Among authors: farrell pm. Pediatr Pulmonol. 2016 Dec;51(12):1295-1303. doi: 10.1002/ppul.23554. Epub 2016 Oct 14. Pediatr Pulmonol. 2016. PMID: 27740724 Free PMC article.

77

Introduction to "Cystic Fibrosis Foundation Consensus Guidelines for Diagnosis of Cystic Fibrosis".

Farrell PM, White TB. Farrell PM, et al. J Pediatr. 2017 Feb;181S:S1-S3. doi: 10.1016/j.jpeds.2016.09.062. J Pediatr. 2017. PMID: 28129807 No abstract available.

78

Cystic Fibrosis Diagnostic Challenges over 4 Decades: Historical Perspectives and Lessons Learned.

Farrell PM, White TB, Derichs N, Castellani C, Rosenstein BJ. Farrell PM, et al. J Pediatr. 2017 Feb;181S:S16-S26. doi: 10.1016/j.jpeds.2016.09.067. J Pediatr. 2017. PMID: 28129808

79

Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.

Sosnay PR, Salinas DB, White TB, Ren CL, Farrell PM, Raraigh KS, Girodon E, Castellani C. Sosnay PR, et al. Among authors: farrell pm. J Pediatr. 2017 Feb;181S:S27-S32.e1. doi: 10.1016/j.jpeds.2016.09.063. J Pediatr. 2017. PMID: 28129809

80

Diagnosis of Cystic Fibrosis in Screened Populations.

Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, Sommerburg O, Accurso FJ, Davies JC, Rock MJ, Sanders DB, Wilschanski M, Sermet-Gaudelus I, Blau H, Gartner S, McColley SA. Farrell PM, et al. J Pediatr. 2017 Feb;181S:S33-S44.e2. doi: 10.1016/j.jpeds.2016.09.065. J Pediatr. 2017. PMID: 28129810 Free article.

81

Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation.

Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PR. Farrell PM, et al. J Pediatr. 2017 Feb;181S:S4-S15.e1. doi: 10.1016/j.jpeds.2016.09.064. J Pediatr. 2017. PMID: 28129811 Free article.

82

Diagnosis of Cystic Fibrosis in Nonscreened Populations.

Sosnay PR, White TB, Farrell PM, Ren CL, Derichs N, Howenstine MS, Nick JA, De Boeck K. Sosnay PR, et al. Among authors: farrell pm. J Pediatr. 2017 Feb;181S:S52-S57.e2. doi: 10.1016/j.jpeds.2016.09.068. J Pediatr. 2017. PMID: 28129813

83

Poor recovery from cystic fibrosis pulmonary exacerbations is associated with poor long-term outcomes.

Sanders DB, Zhao Q, Li Z, Farrell PM. Sanders DB, et al. Among authors: farrell pm. Pediatr Pulmonol. 2017 Oct;52(10):1268-1275. doi: 10.1002/ppul.23765. Epub 2017 Sep 7. Pediatr Pulmonol. 2017. PMID: 28881091 Free PMC article.

84

Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis.

Sanders DB, Zhang Z, Farrell PM, Lai HJ; Wisconsin CF Neonatal Screening Group. Sanders DB, et al. Among authors: farrell pm. J Cyst Fibros. 2018 Jul;17(4):528-535. doi: 10.1016/j.jcf.2018.01.006. Epub 2018 Feb 1. J Cyst Fibros. 2018. PMID: 29396025 Free PMC article.

85

Quantitative chest computerized tomography and FEV₁ equally identify pulmonary exacerbation risk in children with cystic fibrosis.

Sanders DB, Li Z, Parker-McGill K, Farrell P, Brody AS. Sanders DB, et al. Pediatr Pulmonol. 2018 Oct;53(10):1369-1377. doi: 10.1002/ppul.24144. Epub 2018 Aug 29. Pediatr Pulmonol. 2018. PMID: 30160050 Free PMC article. Clinical Trial.

86

Identification of molecular signatures of cystic fibrosis disease status with plasma-based functional genomics.

Levy H, Jia S, Pan A, Zhang X, Kaldunski M, Nugent ML, Reske M, Feliciano RA, Quintero D, Renda MM, Woods KJ, Murkowski K, Johnson K, Verbsky J, Dasu T, Ideozu JE, McColley S, Quasney MW, Dahmer MK, Avner E, Farrell PM, Cannon CL, Jacob H, Simpson PM, Hessner MJ. Levy H, et al. Among authors: farrell pm. Physiol Genomics. 2019 Jan 1;51(1):27-41. doi: 10.1152/physiolgenomics.00109.2018. Epub 2018 Dec 12. Physiol Genomics. 2019. PMID: 30540547 Free PMC article.

87

Inconclusive diagnosis after a positive newborn bloodspot screening result for cystic fibrosis; clarification of the harmonised international definition.

Southern KW, Barben J, Gartner S, Munck A, Castellani C, Mayell SJ, Davies JC, Winters V, Murphy J, Salinas D, McColley SA, Ren CL, Farrell PM. Southern KW, et al. Among authors: farrell pm. J Cyst Fibros. 2019 Nov;18(6):778-780. doi: 10.1016/j.jcf.2019.04.010. Epub 2019 Apr 24. J Cyst Fibros. 2019. PMID: 31027826 Free article. No abstract available.

88

Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.

Munck A, Bourmaud A, Bellon G, Picq P, Farrell PM; DPAM Study Group. Munck A, et al. Among authors: farrell pm. Pediatr Pulmonol. 2020 Apr;55(4):918-928. doi: 10.1002/ppul.24634. Epub 2020 Jan 9. Pediatr Pulmonol. 2020. PMID: 31916691

89

Applying whole-genome sequencing in relation to phenotype and outcomes in siblings with cystic fibrosis.

Wilk MA, Braun AT, Farrell PM, Laxova A, Brown DM, Holt JM, Birch CL, Sosonkina N, Wilk BM, Worthey EA. Wilk MA, et al. Among authors: farrell pm. Cold Spring Harb Mol Case Stud. 2020 Feb 3;6(1):a004531. doi: 10.1101/mcs.a004531. Print 2020 Feb. Cold Spring Harb Mol Case Stud. 2020. PMID: 32014855 Free PMC article.

90

Experience with Parent Follow-Up for Communication Outcomes after Newborn Screening Identifies Carrier Status.

Farrell MH, La Pean Kirschner A, Tluczek A, Farrell PM. Farrell MH, et al. Among authors: farrell pm. J Pediatr. 2020 Sep;224:37-43.e2. doi: 10.1016/j.jpeds.2020.03.027. Epub 2020 May 6. J Pediatr. 2020. PMID: 32386871 Free PMC article.

91

Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis.

Barreda CB, Farrell PM, Laxova A, Eickhoff JC, Braun AT, Coller RJ, Rock MJ. Barreda CB, et al. Among authors: farrell pm. J Cyst Fibros. 2021 May;20(3):492-498. doi: 10.1016/j.jcf.2020.06.002. Epub 2020 Jun 13. J Cyst Fibros. 2021. PMID: 32546430 Free PMC article.

92

Setting a new standard in cystic fibrosis newborn screening illustrates controversial issues as new data emerge.

Farrell PM. Farrell PM. Eur J Hum Genet. 2020 Oct;28(10):1305-1306. doi: 10.1038/s41431-020-0690-0. Epub 2020 Jul 13. Eur J Hum Genet. 2020. PMID: 32661329 Free PMC article. No abstract available.

93

Vulnerable Child Syndrome and Newborn Screening Carrier Results for Cystic Fibrosis or Sickle Cell.

Farrell MH, Sims AM, La Pean Kirschner A, Farrell PM, Tarini BA. Farrell MH, et al. Among authors: farrell pm. J Pediatr. 2020 Sep;224:44-50.e1. doi: 10.1016/j.jpeds.2020.03.042. J Pediatr. 2020. PMID: 32826027 Free PMC article.

94

Challenging the dogma of the healthy heterozygote: Implications for newborn screening policies and practices.

Farrell PM, Langfelder-Schwind E, Farrell MH. Farrell PM, et al. Among authors: farrell mh. Mol Genet Metab. 2021 Sep-Oct;134(1-2):8-19. doi: 10.1016/j.ymgme.2021.08.008. Epub 2021 Aug 21. Mol Genet Metab. 2021. PMID: 34483044 Review.

95

Genetic counseling access for parents of newborns who screen positive for cystic fibrosis: Consensus guidelines.

Langfelder-Schwind E, Raraigh KS; CF Newborn Screening Genetic Counseling Workgroup; Parad RB. Langfelder-Schwind E, et al. Pediatr Pulmonol. 2022 Apr;57(4):894-902. doi: 10.1002/ppul.25806. Epub 2022 Jan 11. Pediatr Pulmonol. 2022. PMID: 34964558

96

Vitamins A, D, E status as related to supplementation and lung disease markers in young children with cystic fibrosis.

Lai HJ, Chin LH, Murali S, Bach T, Sander D, Farrell PM; FIRST Study Group. Lai HJ, et al. Among authors: farrell pm. Pediatr Pulmonol. 2022 Apr;57(4):935-944. doi: 10.1002/ppul.25825. Epub 2022 Jan 20. Pediatr Pulmonol. 2022. PMID: 35018747 Free PMC article.

97

Defining and identifying early-onset lung disease in cystic fibrosis with cumulative clinical characteristics.

Huang L, Lai HJ, Antos N, Rock MJ, Asfour F, Howenstine M, Gaffin JM, Farrell PM. Huang L, et al. Among authors: farrell pm. Pediatr Pulmonol. 2022 Oct;57(10):2363-2373. doi: 10.1002/ppul.26040. Epub 2022 Jun 25. Pediatr Pulmonol. 2022. PMID: 35712759 Free PMC article.

98

Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening.

McColley SA, Martiniano SL, Ren CL, Sontag MK, Rychlik K, Balmert L, Elbert A, Wu R, Farrell PM. McColley SA, et al. Among authors: farrell pm. J Cyst Fibros. 2023 Jan;22(1):89-97. doi: 10.1016/j.jcf.2022.07.010. Epub 2022 Jul 22. J Cyst Fibros. 2023. PMID: 35871976 Free article.

99

Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United States.

Sontag MK, Miller JI, McKasson S, Gaviglio A, Martiniano SL, West R, Vazquez M, Ren CL, Farrell PM, McColley SA, Kellar-Guenther Y. Sontag MK, et al. Among authors: farrell pm. Int J Neonatal Screen. 2022 Jun 23;8(3):38. doi: 10.3390/ijns8030038. Int J Neonatal Screen. 2022. PMID: 35892468 Free PMC article.

100

Detection of disease-causing CFTR variants in state newborn screening programs.

McGarry ME, Ren CL, Wu R, Farrell PM, McColley SA. McGarry ME, et al. Among authors: farrell pm. Pediatr Pulmonol. 2023 Feb;58(2):465-474. doi: 10.1002/ppul.26209. Epub 2022 Oct 25. Pediatr Pulmonol. 2023. PMID: 36237137 Free PMC article.

101

Refinement of newborn screening for cystic fibrosis with next generation sequencing.

Rock MJ, Baker M, Antos N, Farrell PM. Rock MJ, et al. Among authors: farrell pm. Pediatr Pulmonol. 2023 Mar;58(3):778-787. doi: 10.1002/ppul.26253. Epub 2022 Dec 5. Pediatr Pulmonol. 2023. PMID: 36416003

102

Variation in cystic fibrosis newborn screening algorithms in the United States.

Rehani MR, Marcus MS, Harris AB, Farrell PM, Ren CL. Rehani MR, et al. Among authors: farrell pm. Pediatr Pulmonol. 2023 Mar;58(3):927-933. doi: 10.1002/ppul.26279. Epub 2022 Dec 16. Pediatr Pulmonol. 2023. PMID: 36507555

103

Cystic fibrosis screen-positive neonates with one pathogenic variant still warrant sweat testing.

Rock MJ, Baker M, Farrell PM. Rock MJ, et al. Among authors: farrell pm. Pediatr Pulmonol. 2023 Nov;58(11):3342-3345. doi: 10.1002/ppul.26621. Epub 2023 Jul 28. Pediatr Pulmonol. 2023. PMID: 37503874 No abstract available.

104

Impact of intrinsic and extrinsic risk factors on early-onset lung disease in cystic fibrosis.

Huang L, Lai HJ, Song J, Zhao Z, Lu Q, Murali SG, Brown DM, Worthey EA, Farrell PM. Huang L, et al. Among authors: farrell pm. Pediatr Pulmonol. 2023 Nov;58(11):3071-3082. doi: 10.1002/ppul.26625. Epub 2023 Aug 4. Pediatr Pulmonol. 2023. PMID: 37539852

105

Severe lung disease in children with cystic fibrosis missed in newborn screening.

Baldwin K, Barker EM, Carayannopoulos M, Farrell PM, Zanni R, Scanlin TF. Baldwin K, et al. Among authors: farrell pm. Pediatr Pulmonol. 2024 Jan;59(1):163-168. doi: 10.1002/ppul.26734. Epub 2023 Oct 27. Pediatr Pulmonol. 2024. PMID: 37888495 Review.

106

Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum lipids in patients with cystic fibrosis.

Rettammel AL, Marcus MS, Farrell PM, Sondel SA, Koscik RE, Mischler EH. Rettammel AL, et al. Among authors: farrell pm. J Am Diet Assoc. 1995 Apr;95(4):454-9. doi: 10.1016/S0002-8223(95)00121-2. J Am Diet Assoc. 1995. PMID: 7699188 Clinical Trial.

107

Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.

Gregg RG, Simantel A, Farrell PM, Koscik R, Kosorok MR, Laxova A, Laessig R, Hoffman G, Hassemer D, Mischler EH, Splaingard M. Gregg RG, et al. Among authors: farrell pm. Pediatrics. 1997 Jun;99(6):819-24. doi: 10.1542/peds.99.6.819. Pediatrics. 1997. PMID: 9164776

108

State-to-state variations in newborn screening policies.

Stoddard JJ, Farrell PM. Stoddard JJ, et al. Among authors: farrell pm. Arch Pediatr Adolesc Med. 1997 Jun;151(6):561-4. doi: 10.1001/archpedi.1997.02170430027005. Arch Pediatr Adolesc Med. 1997. PMID: 9193238

109

Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis.

Lai HC, FitzSimmons SC, Allen DB, Kosorok MR, Rosenstein BJ, Campbell PW, Farrell PM. Lai HC, et al. Among authors: farrell pm. N Engl J Med. 2000 Mar 23;342(12):851-9. doi: 10.1056/NEJM200003233421204. N Engl J Med. 2000. PMID: 10727589 Free article. Clinical Trial.

110

The magnitude and challenge of false-positive newborn screening test results.

Kwon C, Farrell PM. Kwon C, et al. Among authors: farrell pm. Arch Pediatr Adolesc Med. 2000 Jul;154(7):714-8. doi: 10.1001/archpedi.154.7.714. Arch Pediatr Adolesc Med. 2000. PMID: 10891024

111

Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML. Farrell PM, et al. Pediatrics. 2001 Jan;107(1):1-13. doi: 10.1542/peds.107.1.1. Pediatrics. 2001. PMID: 11134427 Clinical Trial.

112

Assessing the quality of life in children with cystic fibrosis.

Kotwicki RJ, Condra L, Vermeulen L, Wolf T, Douglas J, Farrell PM. Kotwicki RJ, et al. Among authors: farrell pm. WMJ. 2001;100(5):50-4. WMJ. 2001. PMID: 11579801

113

Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.

West SE, Zeng L, Lee BL, Kosorok MR, Laxova A, Rock MJ, Splaingard MJ, Farrell PM. West SE, et al. Among authors: farrell pm. JAMA. 2002 Jun 12;287(22):2958-67. doi: 10.1001/jama.287.22.2958. JAMA. 2002. PMID: 12052125

114

Newborn screening for cystic fibrosis: ensuring more good than harm.

Farrell MH, Farrell PM. Farrell MH, et al. Among authors: farrell pm. J Pediatr. 2003 Dec;143(6):707-12. doi: 10.1016/j.jpeds.2003.09.022. J Pediatr. 2003. PMID: 14657812 Review. No abstract available.

115

Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis.

Lai HJ, Cheng Y, Cho H, Kosorok MR, Farrell PM. Lai HJ, et al. Among authors: farrell pm. Am J Epidemiol. 2004 Mar 15;159(6):537-46. doi: 10.1093/aje/kwh083. Am J Epidemiol. 2004. PMID: 15003957

116

Cystic fibrosis newborn screening: shifting the key question from "should we screen?" to "how should we screen?".

Farrell PM. Farrell PM. Pediatrics. 2004 Jun;113(6):1811-2. doi: 10.1542/peds.113.6.1811. Pediatrics. 2004. PMID: 15173512 No abstract available.

117

Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.

Tluczek A, Koscik RL, Farrell PM, Rock MJ. Tluczek A, et al. Among authors: farrell pm. Pediatrics. 2005 Jun;115(6):1692-703. doi: 10.1542/peds.2004-0275. Pediatrics. 2005. PMID: 15930234

118

Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.

Koscik RL, Lai HJ, Laxova A, Zaremba KM, Kosorok MR, Douglas JA, Rock MJ, Splaingard ML, Farrell PM. Koscik RL, et al. Among authors: farrell pm. J Pediatr. 2005 Sep;147(3 Suppl):S51-6. doi: 10.1016/j.jpeds.2005.08.003. J Pediatr. 2005. PMID: 16202783

119

Quality of life of children with cystic fibrosis.

Koscik RL, Douglas JA, Zaremba K, Rock MJ, Splaingard ML, Laxova A, Farrell PM. Koscik RL, et al. Among authors: farrell pm. J Pediatr. 2005 Sep;147(3 Suppl):S64-8. doi: 10.1016/j.jpeds.2005.09.001. J Pediatr. 2005. PMID: 16202786

120

Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

Braun AT, Farrell PM, Ferec C, Audrezet MP, Laxova A, Li Z, Kosorok MR, Rosenberg MA, Gershan WM. Braun AT, et al. Among authors: farrell pm. J Cyst Fibros. 2006 Jan;5(1):33-41. doi: 10.1016/j.jcf.2005.09.008. Epub 2005 Nov 4. J Cyst Fibros. 2006. PMID: 16275171 Free article. Clinical Trial.

121

Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis.

Grosse SD, Rosenfeld M, Devine OJ, Lai HJ, Farrell PM. Grosse SD, et al. Among authors: farrell pm. J Pediatr. 2006 Sep;149(3):362-6. doi: 10.1016/j.jpeds.2006.04.059. J Pediatr. 2006. PMID: 16939748 Review.

122

The meaning of "early" diagnosis in a new era of cystic fibrosis care.

Farrell PM. Farrell PM. Pediatrics. 2007 Jan;119(1):156-7. doi: 10.1542/peds.2006-3074. Pediatrics. 2007. PMID: 17200282 No abstract available.

123

The prevalence of cystic fibrosis in the European Union.

Farrell PM. Farrell PM. J Cyst Fibros. 2008 Sep;7(5):450-3. doi: 10.1016/j.jcf.2008.03.007. Epub 2008 Apr 28. J Cyst Fibros. 2008. PMID: 18442953 Free article.

124

Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis.

Rao AR, Laxova A, Farrell PM, Barbieri JT. Rao AR, et al. Among authors: farrell pm. J Clin Microbiol. 2009 Aug;47(8):2483-8. doi: 10.1128/JCM.02182-08. Epub 2009 Jun 24. J Clin Microbiol. 2009. PMID: 19553571 Free PMC article.

125

Associations between academic achievement and psychosocial variables in adolescents with cystic fibrosis.

Grieve AJ, Tluczek A, Racine-Gilles CN, Laxova A, Albers CA, Farrell PM. Grieve AJ, et al. Among authors: farrell pm. J Sch Health. 2011 Nov;81(11):713-20. doi: 10.1111/j.1746-1561.2011.00648.x. J Sch Health. 2011. PMID: 21972992 Free PMC article.

126

Improving communication between doctors and parents after newborn screening.

Farrell MH, Christopher SA, Tluczek A, Kennedy-Parker K, La Pean A, Eskra K, Collins J, Hoffman G, Panepinto J, Farrell PM. Farrell MH, et al. Among authors: farrell pm. WMJ. 2011 Oct;110(5):221-7. WMJ. 2011. PMID: 22164579 Free PMC article.

127

Effects of immediate telephone follow-up with providers on sweat chloride test timing after cystic fibrosis newborn screening identifies a single mutation.

La Pean A, Farrell MH, Eskra KL, Farrell PM. La Pean A, et al. Among authors: farrell pm, farrell mh. J Pediatr. 2013 Mar;162(3):522-9. doi: 10.1016/j.jpeds.2012.08.055. Epub 2012 Oct 24. J Pediatr. 2013. PMID: 23102590 Free PMC article.

128

Improving the quality of physician communication with rapid-throughput analysis and report cards.

Farrell MH, Christopher SA, La Pean Kirschner A, Roedl SJ, O'Tool FO, Ahmad NY, Farrell PM. Farrell MH, et al. Among authors: farrell pm. Patient Educ Couns. 2014 Nov;97(2):248-55. doi: 10.1016/j.pec.2014.07.028. Epub 2014 Aug 28. Patient Educ Couns. 2014. PMID: 25224315 Free PMC article. Clinical Trial.

129

Cystic fibrosis newborn screening: a model for neuromuscular disease screening?

Scully MA, Farrell PM, Ciafaloni E, Griggs RC, Kwon JM. Scully MA, et al. Among authors: farrell pm. Ann Neurol. 2015 Feb;77(2):189-97. doi: 10.1002/ana.24316. Epub 2014 Dec 13. Ann Neurol. 2015. PMID: 25425541 Review.

130

Toward quality improvement in cystic fibrosis newborn screening: Progress and continuing challenges.

Farrell PM, Sommerburg O. Farrell PM, et al. J Cyst Fibros. 2016 May;15(3):267-9. doi: 10.1016/j.jcf.2016.04.008. Epub 2016 May 10. J Cyst Fibros. 2016. PMID: 27172835 Free article. No abstract available.

131

Access to Primary Care and Subspecialty Care After Positive Cystic Fibrosis Newborn Screening.

Parker-McGill K, Rosenberg M, Farrell P. Parker-McGill K, et al. WMJ. 2016 Dec;115(6):295-9. WMJ. 2016. PMID: 29094862 Free PMC article.

132

The future of cystic fibrosis care: a global perspective.

Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-Hamblett N, Kashirskaya N, Kerem E, Mathew JL, McKone EF, Naehrlich L, Nasr SZ, Oates GR, O'Neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F. Bell SC, et al. Among authors: farrell pm. Lancet Respir Med. 2020 Jan;8(1):65-124. doi: 10.1016/S2213-2600(19)30337-6. Epub 2019 Sep 27. Lancet Respir Med. 2020. PMID: 31570318 Free PMC article. Review.

133

Newborn Screening for CF across the Globe-Where Is It Worthwhile?

Scotet V, Gutierrez H, Farrell PM. Scotet V, et al. Among authors: farrell pm. Int J Neonatal Screen. 2020 Mar 4;6(1):18. doi: 10.3390/ijns6010018. eCollection 2020 Mar. Int J Neonatal Screen. 2020. PMID: 33073015 Free PMC article. Review.

134

[No title available]

[No authors listed] [No authors listed] PMID: 33561097

135

Genetic factors help explain the variable responses of young children with cystic fibrosis to vitamin D supplements.

Lai HJ, Song J, Lu Q, Murali SG, Gajapathy M, Wilk BM, Brown DM, Worthey EA, Farrell PM; FIRST Study Group. Lai HJ, et al. Among authors: farrell pm. Clin Nutr ESPEN. 2022 Oct;51:367-376. doi: 10.1016/j.clnesp.2022.07.018. Epub 2022 Aug 8. Clin Nutr ESPEN. 2022. PMID: 36184229

136

Progressive malnutrition, severe anemia, hepatic dysfunction, and respiratory failure in a three-month-old white girl.

Farrell P, Gilbert-Barness E, Bell J, Gregg R, Mischler E, Odell G, Shahidi N, Robertson I, Evans J. Farrell P, et al. Am J Med Genet. 1993 Mar 15;45(6):725-38. doi: 10.1002/ajmg.1320450613. Am J Med Genet. 1993. PMID: 8456852 No abstract available.

137

Long-term evaluation of genetic counseling following false-positive newborn screen for cystic fibrosis.

Cavanagh L, Compton CJ, Tluczek A, Brown RL, Farrell PM. Cavanagh L, et al. Among authors: farrell pm. J Genet Couns. 2010 Apr;19(2):199-210. doi: 10.1007/s10897-009-9274-4. Epub 2010 Feb 4. J Genet Couns. 2010. PMID: 20131088 Free PMC article.

138

Tluczek A, Becker T, Grieve A, Laxova A, Rock MJ, Gershan WM, Green CG, Farrell PM. Tluczek A, et al. Among authors: farrell pm. J Dev Behav Pediatr. 2013 May;34(4):252-61. doi: 10.1097/DBP.0b013e3182905646. J Dev Behav Pediatr. 2013. PMID: 23669872 Free PMC article.

139

The Impact of the CFTR Gene Discovery on Cystic Fibrosis Diagnosis, Counseling, and Preventive Therapy.

Farrell PM, Rock MJ, Baker MW. Farrell PM, et al. Genes (Basel). 2020 Apr 8;11(4):401. doi: 10.3390/genes11040401. Genes (Basel). 2020. PMID: 32276344 Free PMC article. Review.

140

Neonatal screening for cystic fibrosis in Wisconsin.

Mischler E, Farrell P, Bruns T, Rock M, Tluczek A, Colby H, McCarthy C, Hassemer D, Laessig R, Fost N. Mischler E, et al. Wis Med J. 1989 Mar;88(3):14-8. Wis Med J. 1989. PMID: 2728472

141

Correction of linoleic acid deficiency in cystic fibrosis.

Mischler EH, Parrell SW, Farrell PM, Raynor WJ, Lemen RJ. Mischler EH, et al. Among authors: farrell pm. Pediatr Res. 1986 Jan;20(1):36-41. doi: 10.1203/00006450-198601000-00010. Pediatr Res. 1986. PMID: 3456148 Clinical Trial.

142

Fatty acid abnormalities in cystic fibrosis.

Farrell PM, Mischler EH, Engle MJ, Brown DJ, Lau SM. Farrell PM, et al. Pediatr Res. 1985 Jan;19(1):104-9. doi: 10.1203/00006450-198501000-00028. Pediatr Res. 1985. PMID: 3918287

143

Immunoreactive Trypsinogen (IRT) as a Biomarker for Cystic Fibrosis: challenges in newborn dried blood spot screening.

Therrell BL Jr, Hannon WH, Hoffman G, Ojodu J, Farrell PM. Therrell BL Jr, et al. Among authors: farrell pm. Mol Genet Metab. 2012 May;106(1):1-6. doi: 10.1016/j.ymgme.2012.02.013. Epub 2012 Feb 28. Mol Genet Metab. 2012. PMID: 22425451

144

Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis.

Corech R, Rao A, Laxova A, Moss J, Rock MJ, Li Z, Kosorok MR, Splaingard ML, Farrell PM, Barbieri JT. Corech R, et al. Among authors: farrell pm. J Clin Microbiol. 2005 Aug;43(8):3956-62. doi: 10.1128/JCM.43.8.3956-3962.2005. J Clin Microbiol. 2005. PMID: 16081936 Free PMC article.

145

Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis.

Brody AS, Kosorok MR, Li Z, Broderick LS, Foster JL, Laxova A, Bandla H, Farrell PM. Brody AS, et al. Among authors: farrell pm. J Thorac Imaging. 2006 Mar;21(1):14-21. doi: 10.1097/01.rti.0000203937.82276.ce. J Thorac Imaging. 2006. PMID: 16538150 Clinical Trial.

146

Poor recovery from a pulmonary exacerbation does not lead to accelerated FEV₁ decline.

Sanders DB, Li Z, Zhao Q, Farrell PM. Sanders DB, et al. Among authors: farrell pm. J Cyst Fibros. 2017 Jul 29:S1569-1993(17)30818-4. doi: 10.1016/j.jcf.2017.07.003. Online ahead of print. J Cyst Fibros. 2017. PMID: 28765072 Free PMC article.

147

Long-term mechanical ventilation in pediatric respiratory failure: medical and ethical considerations.

Farrell PM, Fost NC. Farrell PM, et al. Am Rev Respir Dis. 1989 Aug;140(2 Pt 2):S36-40. doi: 10.1164/ajrccm/140.2_Pt_2.S36. Am Rev Respir Dis. 1989. PMID: 2504092

148

Early diagnosis of cystic fibrosis.

Grosse SD, Khoury MJ, Hannon WH, Boyle CA, Farrell PM. Grosse SD, et al. Among authors: farrell pm. Pediatrics. 2001 Jun;107(6):1492. doi: 10.1542/peds.107.6.1492. Pediatrics. 2001. PMID: 11400707 No abstract available.

149

Multiplexed genetic analysis using an expanded genetic alphabet.

Johnson SC, Marshall DJ, Harms G, Miller CM, Sherrill CB, Beaty EL, Lederer SA, Roesch EB, Madsen G, Hoffman GL, Laessig RH, Kopish GJ, Baker MW, Benner SA, Farrell PM, Prudent JR. Johnson SC, et al. Among authors: farrell pm. Clin Chem. 2004 Nov;50(11):2019-27. doi: 10.1373/clinchem.2004.034330. Epub 2004 Aug 19. Clin Chem. 2004. PMID: 15319316 Free PMC article.

150

Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis.

Rosenfeld M, Farrell PM, Kloster M, Swanson JO, Vu T, Brumback L, Acton JD, Castile RG, Colin AA, Conrad CK, Hart MA, Kerby GS, Hiatt PW, Mogayzel PJ, Johnson RC, Davis SD. Rosenfeld M, et al. Among authors: farrell pm. Eur Respir J. 2013 Dec;42(6):1545-52. doi: 10.1183/09031936.00138412. Epub 2013 May 30. Eur Respir J. 2013. PMID: 23722613 Free PMC article.

151

The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis.

Farrell PM, Bieri JG, Fratantoni JF, Wood RE, di Sant'Agnese PA. Farrell PM, et al. J Clin Invest. 1977 Jul;60(1):233-41. doi: 10.1172/JCI108760. J Clin Invest. 1977. PMID: 874086 Free PMC article.

152

Intravenous infusion of lipid for the prevention of essential fatty acid deficiency in premature infants.

Gutcher GR, Farrell PM. Gutcher GR, et al. Among authors: farrell pm. Am J Clin Nutr. 1991 Dec;54(6):1024-8. doi: 10.1093/ajcn/54.6.1024. Am J Clin Nutr. 1991. PMID: 1957817

153

A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma.

Fost N, Farrell PM. Fost N, et al. Among authors: farrell pm. Clin Res. 1989 Sep;37(3):495-500. Clin Res. 1989. PMID: 2673641 Clinical Trial. No abstract available.

154

Discordance between male and female deaths due to the respiratory distress syndrome.

Perelman RH, Palta M, Kirby R, Farrell PM. Perelman RH, et al. Among authors: farrell pm. Pediatrics. 1986 Aug;78(2):238-44. Pediatrics. 1986. PMID: 3737300

155

An evaluation of vitamin E status in premature infants.

Gutcher GR, Raynor WJ, Farrell PM. Gutcher GR, et al. Among authors: farrell pm. Am J Clin Nutr. 1984 Nov;40(5):1078-89. doi: 10.1093/ajcn/40.5.1078. Am J Clin Nutr. 1984. PMID: 6496387

156

Evaluation of vitamin E deficiency in children with lung disease.

Farrell PM, Mischler EH, Gutcher GR. Farrell PM, et al. Ann N Y Acad Sci. 1982;393:96-108. doi: 10.1111/j.1749-6632.1982.tb31236.x. Ann N Y Acad Sci. 1982. PMID: 6959573

157

Granulocyte chemiluminescence in adolescent patients with cystic fibrosis.

Graft DF, Mischler E, Farrell PM, Busse WW. Graft DF, et al. Among authors: farrell pm. Am Rev Respir Dis. 1982 May;125(5):540-3. doi: 10.1164/arrd.1982.125.5.540. Am Rev Respir Dis. 1982. PMID: 7081813

158

Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis.

Mischler EH, Parrell S, Farrell PM, Odell GB. Mischler EH, et al. Among authors: farrell pm. Am J Dis Child. 1982 Dec;136(12):1060-3. doi: 10.1001/archpedi.1982.03970480026006. Am J Dis Child. 1982. PMID: 7148760 Clinical Trial.

159

Analysis of granulocyte beta-adrenergic response in cystic fibrosis: correlation of decreased responsiveness with disease severity.

Lemanske RF Jr, Mischler EH, Farrell PM, Anderson C, Busse WW. Lemanske RF Jr, et al. Among authors: farrell pm. Am Rev Respir Dis. 1981 Jun;123(6):622-6. doi: 10.1164/arrd.1981.123.6.622. Am Rev Respir Dis. 1981. PMID: 7271056

160

Transformative mutation specific pharmacotherapy for cystic fibrosis.

Sanders DB, Farrell PM. Sanders DB, et al. Among authors: farrell pm. BMJ. 2012 Jan 9;344:e79. doi: 10.1136/bmj.e79. BMJ. 2012. PMID: 22232540 No abstract available.

161

25-Hydroxycholecalciferol levels in patients with cystic fibrosis.

Hubbard VS, Farrell PM, di Sant'Agnese PA. Hubbard VS, et al. Among authors: farrell pm. J Pediatr. 1979 Jan;94(1):84-6. doi: 10.1016/s0022-3476(79)80362-5. J Pediatr. 1979. PMID: 758431 No abstract available.

162

Electrolyte values of sweat obtained by local and whole body collection methods in cystic fibrosis patients.

Cohen LF, Farrell PM, Lundgren DW, di Sant'Agnese PA. Cohen LF, et al. Among authors: farrell pm. J Pediatr. 1976 Sep;89(3):430-3. doi: 10.1016/s0022-3476(76)80543-4. J Pediatr. 1976. PMID: 956970 No abstract available.

163

Essential fatty acid deficiency in premature infants.

Farrell PM, Gutcher GR, Palta M, DeMets D. Farrell PM, et al. Am J Clin Nutr. 1988 Aug;48(2):220-9. doi: 10.1093/ajcn/48.2.220. Am J Clin Nutr. 1988. PMID: 3407602

164

Vitamin E, vitamin A and essential fatty acid status of patients hospitalized for anorexia nervosa.

Langan SM, Farrell PM. Langan SM, et al. Among authors: farrell pm. Am J Clin Nutr. 1985 May;41(5):1054-60. doi: 10.1093/ajcn/41.5.1054. Am J Clin Nutr. 1985. PMID: 3993608

165

Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa.

Banwart B, Splaingard ML, Farrell PM, Rock MJ, Havens PL, Moss J, Ehrmantraut ME, Frank DW, Barbieri JT. Banwart B, et al. Among authors: farrell pm. J Infect Dis. 2002 Jan 15;185(2):269-70. doi: 10.1086/338197. J Infect Dis. 2002. PMID: 11807706 No abstract available.

166

Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms.

Férec C, Casals T, Chuzhanova N, Macek M Jr, Bienvenu T, Holubova A, King C, McDevitt T, Castellani C, Farrell PM, Sheridan M, Pantaleo SJ, Loumi O, Messaoud T, Cuppens H, Torricelli F, Cutting GR, Williamson R, Ramos MJ, Pignatti PF, Raguénès O, Cooper DN, Audrézet MP, Chen JM. Férec C, et al. Among authors: farrell pm. Eur J Hum Genet. 2006 May;14(5):567-76. doi: 10.1038/sj.ejhg.5201590. Eur J Hum Genet. 2006. PMID: 16493442

167

Complete ascertainment of intragenic copy number mutations (CNMs) in the CFTR gene and its implications for CNM formation at other autosomal loci.

Quemener S, Chen JM, Chuzhanova N, Bénech C, Casals T, Macek M Jr, Bienvenu T, McDevitt T, Farrell PM, Loumi O, Messaoud T, Cuppens H, Cutting GR, Stenson PD, Giteau K, Audrézet MP, Cooper DN, Férec C. Quemener S, et al. Among authors: farrell pm. Hum Mutat. 2010 Apr;31(4):421-8. doi: 10.1002/humu.21196. Hum Mutat. 2010. PMID: 20052766 Free PMC article.

168

Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening.

Earley MC, Laxova A, Farrell PM, Driscoll-Dunn R, Cordovado S, Mogayzel PJ Jr, Konstan MW, Hannon WH. Earley MC, et al. Among authors: farrell pm. Clin Chim Acta. 2011 Jul 15;412(15-16):1376-81. doi: 10.1016/j.cca.2011.04.011. Epub 2011 Apr 14. Clin Chim Acta. 2011. PMID: 21514289 Free PMC article.

169

CFTR mutation analysis and haplotype associations in CF patients.

Cordovado SK, Hendrix M, Greene CN, Mochal S, Earley MC, Farrell PM, Kharrazi M, Hannon WH, Mueller PW. Cordovado SK, et al. Among authors: farrell pm. Mol Genet Metab. 2012 Feb;105(2):249-54. doi: 10.1016/j.ymgme.2011.10.013. Epub 2011 Oct 26. Mol Genet Metab. 2012. PMID: 22137130 Free PMC article.

170

Vitamin E deficiency in premature infants.

Farrell PM. Farrell PM. J Pediatr. 1979 Nov;95(5 Pt 2):869-72. doi: 10.1016/s0022-3476(79)80456-4. J Pediatr. 1979. PMID: 490264 No abstract available.

171

Megavitamin E supplementation in man.

Farrell PM, Bieri JG. Farrell PM, et al. Am J Clin Nutr. 1975 Dec;28(12):1381-6. doi: 10.1093/ajcn/28.12.1381. Am J Clin Nutr. 1975. PMID: 803000

172

Epidemiology of hyaline membrane disease in the United States: analysis of national mortality statistics.

Farrell PM, Wood RE. Farrell PM, et al. Pediatrics. 1976 Aug;58(2):167-76. Pediatrics. 1976. PMID: 951131

173

Fetal lung development in male and female nonhuman primates.

Perelman RH, Engle MJ, Palta M, Kemnitz JW, Farrell PM. Perelman RH, et al. Among authors: farrell pm. Pediatr Res. 1986 Oct;20(10):987-91. doi: 10.1203/00006450-198610000-00019. Pediatr Res. 1986. PMID: 3774413

174

Essential fatty acid deficiency after hepatic portoenterostomy for biliary atresia.

Gourley GR, Farrell PM, Odell GB. Gourley GR, et al. Among authors: farrell pm. Am J Clin Nutr. 1982 Dec;36(6):1194-9. doi: 10.1093/ajcn/36.6.1194. Am J Clin Nutr. 1982. PMID: 7148738

175

Effects of maternal dexamethasone therapy on fetal lung development in the rhesus monkey.

Engle MJ, Kemnitz JW, Rao TJ, Perelman RH, Farrell PM. Engle MJ, et al. Among authors: farrell pm. Am J Perinatol. 1996 Oct;13(7):399-407. doi: 10.1055/s-2007-994378. Am J Perinatol. 1996. PMID: 8960608

176

Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline.

Wood RE, Wanner A, Hirsch J, Farrell PM. Wood RE, et al. Among authors: farrell pm. Am Rev Respir Dis. 1975 Jun;111(6):733-8. doi: 10.1164/arrd.1975.111.6.733. Am Rev Respir Dis. 1975. PMID: 1137241

177

Polyamine alterations in blood of male homozygotes and heterozygotes for cystic fibrosis.

Lundgren DW, Farrell PM, Di Sant'Agnese PA. Lundgren DW, et al. Among authors: farrell pm. Clin Chim Acta. 1975 Jul 23;62(2):357-62. doi: 10.1016/0009-8981(75)90248-x. Clin Chim Acta. 1975. PMID: 1149299

178

Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus.

Uno H, Lohmiller L, Thieme C, Kemnitz JW, Engle MJ, Roecker EB, Farrell PM. Uno H, et al. Among authors: farrell pm. Brain Res Dev Brain Res. 1990 May 1;53(2):157-67. doi: 10.1016/0165-3806(90)90002-g. Brain Res Dev Brain Res. 1990. PMID: 2357788

179

Circulating 5-hydroxytryptamine concentrations in preterm newborns.

Schumacher RE, Farrell PM, Olson EB Jr. Schumacher RE, et al. Among authors: farrell pm. Pediatr Pulmonol. 1987 Mar-Apr;3(2):117-22. doi: 10.1002/ppul.1950030214. Pediatr Pulmonol. 1987. PMID: 3588055 Free article.

180

Biochemical maturation of fetal rat lung: a comprehensive study including surfactant determination.

Bourbon JR, Farrell PM, Doucet E, Brown DJ, Valenza C. Bourbon JR, et al. Among authors: farrell pm. Biol Neonate. 1987;52(1):48-60. doi: 10.1159/000242684. Biol Neonate. 1987. PMID: 3620554

181

Changes in surfactant phospholipids in fetal rat lungs from normal and diabetic pregnancies.

Rieutort M, Farrell PM, Engle MJ, Pignol B, Bourbon JR. Rieutort M, et al. Among authors: farrell pm. Pediatr Res. 1986 Jul;20(7):650-4. doi: 10.1203/00006450-198607000-00014. Pediatr Res. 1986. PMID: 3755235

182

Developmental aspects of lung lipids.

Perelman RH, Farrell PM, Engle MJ, Kemnitz JW. Perelman RH, et al. Among authors: farrell pm. Annu Rev Physiol. 1985;47:803-22. doi: 10.1146/annurev.ph.47.030185.004103. Annu Rev Physiol. 1985. PMID: 3888089 Review.

183

Changes in erythrocyte and plasma carnitine concentrations in preterm neonates.

Mares-Perlman JA, Farrell PM, Gutcher GR. Mares-Perlman JA, et al. Among authors: farrell pm. Am J Clin Nutr. 1986 Jan;43(1):77-84. doi: 10.1093/ajcn/43.1.77. Am J Clin Nutr. 1986. PMID: 3942096

184

Early intravenous correction of vitamin E deficiency in premature infants.

Gutcher GR, Farrell PM. Gutcher GR, et al. Among authors: farrell pm. J Pediatr Gastroenterol Nutr. 1985 Aug;4(4):604-9. doi: 10.1097/00005176-198508000-00019. J Pediatr Gastroenterol Nutr. 1985. PMID: 4032176

185

An experimental model for studies of fetal maldevelopment in the diabetic pregnancy.

Kemnitz JW, Perelman RH, Engle MJ, Farrell PM. Kemnitz JW, et al. Among authors: farrell pm. Pediatr Pulmonol. 1985 May-Jun;1(3 Suppl):S79-85. Pediatr Pulmonol. 1985. PMID: 4069805

186

Complications of pregnancy and fetal development.

Farrell PM, Engle MJ, Frantz ID, Goldman AS, Kalkhoff R, Kemnitz JW, Perelman R, Stern JS, Susa JB. Farrell PM, et al. Diabetes. 1982;31(Suppl 1 Pt 2):89-94. doi: 10.2337/diab.31.1.s89. Diabetes. 1982. PMID: 6219019

187

Relationship between the severity of experimental diabetes and altered lung phospholipid metabolism.

Engle MJ, Perelman RH, McMahon KE, Langan SM, Farrell PM. Engle MJ, et al. Among authors: farrell pm. Proc Soc Exp Biol Med. 1984 Jul;176(3):261-7. doi: 10.3181/00379727-176-41869. Proc Soc Exp Biol Med. 1984. PMID: 6233616

188

Amniotic fluid phospholipids after maternal administration of dexamethasone.

Farrell PM, Engle MJ, Zachman RD, Curet LB, Morrison JC, Rao AV, Poole WK. Farrell PM, et al. Am J Obstet Gynecol. 1983 Feb 15;145(4):484-90. doi: 10.1016/0002-9378(83)90322-8. Am J Obstet Gynecol. 1983. PMID: 6337495 Clinical Trial.

189

Saturated phospholipids in amniotic fluid of normal and diabetic pregnancies.

Farrell PM, Engle MJ, Curet LB, Perelman RH, Morrison JC. Farrell PM, et al. Obstet Gynecol. 1984 Jul;64(1):77-85. Obstet Gynecol. 1984. PMID: 6547519

190

Changes in food intake during menstrual cycles and pregnancy of normal and diabetic rhesus monkeys.

Kemnitz JW, Eisele SG, Lindsay KA, Engle MJ, Perelman RH, Farrell PM. Kemnitz JW, et al. Among authors: farrell pm. Diabetologia. 1984 Jan;26(1):60-4. doi: 10.1007/BF00252265. Diabetologia. 1984. PMID: 6706046

191

Perspectives on fetal lung development.

Perelman RH, Engle MJ, Farrell PM. Perelman RH, et al. Among authors: farrell pm. Lung. 1981;159(2):53-80. doi: 10.1007/BF02713900. Lung. 1981. PMID: 7015023 Review. No abstract available.

192

Biochemical and physiological development of fetal rhesus lung.

Perelman RH, Engle MJ, Kemnitz JW, Kotas RV, Farrell PM. Perelman RH, et al. Among authors: farrell pm. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jul;53(1):230-5. doi: 10.1152/jappl.1982.53.1.230. J Appl Physiol Respir Environ Exerc Physiol. 1982. PMID: 7118636

193

Analysis of causes of neonatal death in the United States with specific emphasis on fatal hyaline membrane disease.

Perelman RH, Farrell PM. Perelman RH, et al. Among authors: farrell pm. Pediatrics. 1982 Oct;70(4):570-5. Pediatrics. 1982. PMID: 7122155

194

Utilization of glycogen for phospholipid synthesis in fetal rat lung.

Bourbon JR, Rieutort M, Engle MJ, Farrell PM. Bourbon JR, et al. Among authors: farrell pm. Biochim Biophys Acta. 1982 Aug 18;712(2):382-9. doi: 10.1016/0005-2760(82)90356-3. Biochim Biophys Acta. 1982. PMID: 7126612 No abstract available.

195

The stability of phospholipids in amniotic fluid.

Schwartz DB, Engle MJ, Brown DJ, Farrell PM. Schwartz DB, et al. Among authors: farrell pm. Am J Obstet Gynecol. 1981 Oct 1;141(3):294-8. doi: 10.1016/s0002-9378(16)32635-7. Am J Obstet Gynecol. 1981. PMID: 7282809

196

Pseudomonas serology: confusion, controversy, and challenges.

Farrell PM, Govan JR. Farrell PM, et al. Thorax. 2006 Aug;61(8):645-7. doi: 10.1136/thx.2006.062612. Epub 2006 Jun 12. Thorax. 2006. PMID: 16769714 Free PMC article.

197

Effect of choline deficiency on lung phospholipid concentrations in the rat.

McMahon KE, Farrell PM. McMahon KE, et al. Among authors: farrell pm. J Nutr. 1986 Jun;116(6):936-43. doi: 10.1093/jn/116.6.936. J Nutr. 1986. PMID: 3755165

198

The impact of perinatal intensive care and regionalization in Wisconsin.

Perelman R, Farrell PM. Perelman R, et al. Among authors: farrell pm. Wis Med J. 1978 Mar;77(3):S35-S36. Wis Med J. 1978. PMID: 636461 No abstract available.

199

Relationships among surfactant fraction lipids, proteins and biophysical properties in the developing rat lung.

Farrell PM, Bourbon JR, Notter RH, Marin L, Nogee LM, Whitsett JA. Farrell PM, et al. Biochim Biophys Acta. 1990 May 1;1044(1):84-90. doi: 10.1016/0005-2760(90)90222-j. Biochim Biophys Acta. 1990. PMID: 2340311

200

Fetal lung lecithin metabolism in the glucose-intolerant Rhesus monkey pregnancy.

Epstein MF, Farrell PM, Chez RA. Epstein MF, et al. Among authors: farrell pm. Pediatrics. 1976 May;57(5):722-8. Pediatrics. 1976. PMID: 133326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page